Lv11
70 积分 2024-11-12 加入
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
44分钟前
待确认
Perforin and granzymes: function, dysfunction and human pathology
9天前
已完结
Reduced CAR T expansion post infusion is associated with poor survival in patients with large B cell lymphoma after two or more therapies
22天前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
1个月前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
2个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
3个月前
已关闭
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
3个月前
已完结
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
3个月前
已完结
皖公网安备34019202002308
